Stay updated on CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Sign up to get notified when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.

Latest updates to the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', indicating enrollment is closed. The update also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), standardizes the Intervention/Treatment heading, and updates the revision label from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check18 days agoChange DetectedThe page footer now displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates a new build of the page rather than changes to the study content.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page's revision label has been updated from v3.5.3 to v3.5.4, indicating a newer revision of the page content. This change does not modify study details or results.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page’s footer “Revision” version number was updated from v3.5.2 to v3.5.3, indicating a platform/document revision rather than a change to study information.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.0%

Stay in the know with updates to CV301-Nivolumab Combo in Metastatic CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CV301-Nivolumab Combo in Metastatic CRC Clinical Trial page.